Western Blot: Clinical Trials

5 trials of Western Blot, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 2
Phase 12Terminated 2

Follow Western Blot: new trials by email Literature Review of Western Blot trials Research Report on Western Blot

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
panobinostat, laboratory biomarker analysis, western blotting - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 2CompletedMayo Clinic412011-01-172022-05-24
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)22010-10-012017-08-08
Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma
pegfilgrastim, rituximab, flow cytometry - Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma
Phase 2CompletedRoswell Park Cancer Institute202007-04-172017-10-09
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
sorafenib tosylate, microarray analysis, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage II Prostate Cancer
Phase 2CompletedUniversity of Washington52006-12-012017-11-22
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma
Phase 1 / Phase 2TerminatedCity of Hope Medical Center292006-03-012015-04-01

Conditions studied

Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Lymphoma, Follicular (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Burkitt Lymphoma (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Liposarcoma (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Mycosis Fungoides (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Prostatic Neoplasms (1)

Sponsors

City of Hope Medical Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Washington (1)

Countries

United States (5)

Top investigators

Evan Yu (1)  ·  Francisco Hernandez-ILizaliturri (1)  ·  Patrick Brown (1)  ·  Patrick Johnston, M.D. (1)  ·  Warren Chow (1)

NIH funding

U01CA070095 (1)